TrialDrug design, development and therapy2025

Pharmacokinetics, Pharmacodynamic, Safety and Tolerability of Fazamorexant, a Novel Dual Orexin Receptor Antagonist: Report of the First-in-Human Study.

Jun Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.